Treating High Risk Leukemia With CD40 Ligand & IL-2 Gene Modified Tumor Vaccine
Clinical trial NCT00058799 · COMPLETED
Trial details
- NCT number
- NCT00058799
- Sponsor
- Baylor College of Medicine
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 1999-06-01
- Primary completion
- 2010-06-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.